Core A - Administrative Core
Core A - Administrative Core
批准号:
10006194
负责人:
Steven Mark Albelda
金额:
$12.94万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-14 至 2023-08-31
关键词:
Advisory CommitteesAntigensBudgetsCancer CenterCellular immunotherapyClinical TrialsCommunicationDataEnsureExpenditureGoalsGood Clinical PracticeGrantIndustryMalignant neoplasm of thoraxMonitorRegulationReportingResearch PersonnelSafetySpecialistStructureT cell therapyUniversitiescohesionexperiencehigh standardmeetingsprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core A. Administrative
Abstract
The goals of the Administrative core will be: 1) coordinate effective interactions among projects,
cores, oversight committees, and NCI staff, 2) provide Data safety and Monitoring support, ensuring
that clinical trials are under the highest standards of “Good Clinical Practices” and that they comply
with all the regulations of the University and other outside agencies, 3) support interactions with the
Cancer Center and the Center for Cellular Immunotherapies, 4) support interactions with Industry,
and 5) provide budget support, such as tracking the expenditures of the program and providing
monthly reports to the investigators. This Core will also monitor Projects and other Cores and
organize a yearly meeting with the External and Internal Advisory Boards. Given these broad
integrative activities, the Core will interact closely with each Project and with the other two Cores in
providing administrative, financial, and coordinating activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
-
批准号:10006192
-
项目类别:
-
资助金额:$51.54万
-
财政年份:2018
-
负责人:Steven Mark Albelda
-
依托单位:
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
-
批准号:10241978
-
项目类别:
-
资助金额:$51.54万
-
财政年份:2018
-
负责人:Steven Mark Albelda
-
依托单位:
Core A - Administrative Core
-
批准号:10241980
-
项目类别:
-
资助金额:$12.94万
-
财政年份:2018
-
负责人:Steven Mark Albelda
-
依托单位:
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
-
批准号:10006051
-
项目类别:
-
资助金额:$210.15万
-
财政年份:2018
-
负责人:Steven Mark Albelda
-
依托单位:
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
-
批准号:10241975
-
项目类别:
-
资助金额:$210.15万
-
财政年份:2018
-
负责人:Steven Mark Albelda
-
依托单位:
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
-
批准号:10215429
-
项目类别:
-
资助金额:$36.83万
-
财政年份:2017
-
负责人:Steven Mark Albelda
-
依托单位:
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
-
批准号:8578578
-
项目类别:
-
资助金额:$35.77万
-
财政年份:2013
-
负责人:Steven Mark Albelda
-
依托单位:
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
-
批准号:9101792
-
项目类别:
-
资助金额:$35.77万
-
财政年份:2013
-
负责人:Steven Mark Albelda
-
依托单位:
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
-
批准号:8739623
-
项目类别:
-
资助金额:$34.69万
-
财政年份:2013
-
负责人:Steven Mark Albelda
-
依托单位:
Genetic Influence on Incidence of Acute Lung Injury
-
批准号:7796690
-
项目类别:
-
资助金额:$35.67万
-
财政年份:2009
-
负责人:Steven Mark Albelda
-
依托单位:
Preclinical Studies
-
批准号:7133575
-
项目类别:
-
资助金额:$16.96万
-
财政年份:2006
-
负责人:Steven Mark Albelda
-
依托单位:
Administration
-
批准号:7133577
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2006
-
负责人:Steven Mark Albelda
-
依托单位:
Genetic Influence on Incidence of Acute Lung Injury
-
批准号:6968184
-
项目类别:
-
资助金额:$42.06万
-
财政年份:2004
-
负责人:Steven Mark Albelda
-
依托单位:
Ovarian selective Adenoviral vector for gene therapy of ovarian cancer
-
批准号:6667427
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2002
-
负责人:Steven Mark Albelda
-
依托单位:
The Role of PECAM in Models of Lung Injury
-
批准号:6534990
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2002
-
负责人:Steven Mark Albelda
-
依托单位:
The Role of PECAM in Models of Lung Injury
-
批准号:6637863
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2002
-
负责人:Steven Mark Albelda
-
依托单位:
The Role of PECAM in Models of Lung Injury
-
批准号:6784705
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2002
-
负责人:Steven Mark Albelda
-
依托单位:
The Role of PECAM in Models of Lung Injury
-
批准号:6936583
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2002
-
负责人:Steven Mark Albelda
-
依托单位:
Ovarian selective Adenoviral vector for gene therapy of ovarian cancer
-
批准号:6504974
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:Steven Mark Albelda
-
依托单位:
Project 2: Evaluation and Augmentation of Anti-tumoral Immune Responses Induced b
-
批准号:8957836
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2001
-
负责人:Steven Mark Albelda
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: